TBX3 and colorectal carcinoma: The identification of the molecular activities of TBX3 in human CRC cells not only explains how its overexpression can increase their metastatic potential, as we previously observed, but also establishes TBX3 as a regulator of metastasis and as a putative target for molecular therapy.